Connection

James Ballenger to Carbamazepine

Back to Details
This is a "connection" page, showing publications James Ballenger has written about Carbamazepine.
James Ballenger
Connection Strength
0.852
Carbamazepine
  1. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. CNS Drugs. 2007; 21(1):47-71.
    View in: PubMed
    Score: 0.266
  2. Refractory rapid cycling unipolar depression responds to lithium and carbamazepine treatment. J Clin Psychiatry. 1989 Sep; 50(9):356-7.
    View in: PubMed
    Score: 0.080
  3. The use of anticonvulsants in manic-depressive illness. J Clin Psychiatry. 1988 Nov; 49 Suppl:21-5.
    View in: PubMed
    Score: 0.076
  4. The clinical use of carbamazepine in affective disorders. J Clin Psychiatry. 1988 Apr; 49 Suppl:13-21.
    View in: PubMed
    Score: 0.073
  5. The efficacy of carbamazepine in affective illness. Adv Biochem Psychopharmacol. 1984; 39:421-37.
    View in: PubMed
    Score: 0.054
  6. Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull. 1984; 20(3):572-84.
    View in: PubMed
    Score: 0.054
  7. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry. 1980 Jul; 137(7):782-90.
    View in: PubMed
    Score: 0.042
  8. Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989 May; 146(5):617-21.
    View in: PubMed
    Score: 0.020
  9. Dopaminergic effects of carbamazepine. Relationship to clinical response in affective illness. Arch Gen Psychiatry. 1986 Apr; 43(4):392-6.
    View in: PubMed
    Score: 0.016
  10. Neuroendocrine effects of carbamazepine in patients with affective illness. Epilepsia. 1986 Mar-Apr; 27(2):156-60.
    View in: PubMed
    Score: 0.016
  11. Effects of carbamazepine on cerebrospinal fluid somatostatin. Psychopharmacology (Berl). 1985; 85(2):210-3.
    View in: PubMed
    Score: 0.014
  12. CSF somatostatin in affective illness and normal volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 1985; 9(4):393-400.
    View in: PubMed
    Score: 0.014
  13. Effects of carbamazepine on noradrenergic mechanisms in affectively ill patients. Psychopharmacology (Berl). 1985; 87(1):59-63.
    View in: PubMed
    Score: 0.014
  14. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry. 1983 Dec; 140(12):1602-4.
    View in: PubMed
    Score: 0.013
  15. Carbamazepine diminishes the sensitivity of the plasma arginine vasopressin response to osmotic stimulation. J Clin Endocrinol Metab. 1983 Nov; 57(5):952-7.
    View in: PubMed
    Score: 0.013
  16. Carbamazepine and its -10,11-epoxide metabolite in plasma and CSF. Relationship to antidepressant response. Arch Gen Psychiatry. 1983 Jun; 40(6):673-6.
    View in: PubMed
    Score: 0.013
  17. Carbamazepine in alcohol withdrawal syndromes: relationship to the kindling model. J Clin Psychopharmacol. 1983 Jun; 3(3):204-5.
    View in: PubMed
    Score: 0.013
  18. Biochemical effects of carbamazepine: relationship to its mechanisms of action in affective illness. Prog Neuropsychopharmacol Biol Psychiatry. 1983; 7(2-3):263-71.
    View in: PubMed
    Score: 0.013
  19. Kindling and carbamazepine in affective illness. J Nerv Ment Dis. 1982 Dec; 170(12):717-31.
    View in: PubMed
    Score: 0.013
  20. Effect of carbamazepine on cyclic nucleotides in CSF of patients with affective illness. Biol Psychiatry. 1982 Sep; 17(9):1037-45.
    View in: PubMed
    Score: 0.012
  21. Effect of carbamazepine on CSF opioid activity; relationship to antidepressant response. Psychiatry Res. 1981 Aug; 5(1):59-66.
    View in: PubMed
    Score: 0.011
  22. Lack of effect of carbamazepine on gamma-aminobutyric acid in cerebrospinal fluid. Neurology. 1980 Sep; 30(9):1008-11.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.